X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs SHASUN PHARMA - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK SHASUN PHARMA MERCK/
SHASUN PHARMA
 
P/E (TTM) x 56.7 123.9 45.8% View Chart
P/BV x 8.5 8.5 99.8% View Chart
Dividend Yield % 0.4 0.2 171.0%  

Financials

 MERCK   SHASUN PHARMA
EQUITY SHARE DATA
    MERCK
Dec-17
SHASUN PHARMA
Mar-14
MERCK/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,35894 1,441.1%   
Low Rs93346 2,046.1%   
Sales per share (Unadj.) Rs665.0214.2 310.5%  
Earnings per share (Unadj.) Rs56.65.3 1,060.2%  
Cash flow per share (Unadj.) Rs72.515.8 458.1%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %1.31.4 91.6%  
Book value per share (Unadj.) Rs441.753.3 828.1%  
Shares outstanding (eoy) m16.6056.62 29.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 527.7%   
Avg P/E ratio x20.213.1 154.5%  
P/CF ratio (eoy) x15.84.4 357.6%  
Price / Book Value ratio x2.61.3 197.9%  
Dividend payout %26.518.7 141.5%   
Avg Mkt Cap Rs m19,0113,958 480.4%   
No. of employees `0001.5NA-   
Total wages/salary Rs m1,6962,164 78.4%   
Avg. sales/employee Rs Th7,150.0NM-  
Avg. wages/employee Rs Th1,098.7NM-  
Avg. net profit/employee Rs Th608.2NM-  
INCOME DATA
Net Sales Rs m11,04012,127 91.0%  
Other income Rs m240229 104.5%   
Total revenues Rs m11,27912,356 91.3%   
Gross profit Rs m1,3761,009 136.4%  
Depreciation Rs m264594 44.5%   
Interest Rs m0415 0.0%   
Profit before tax Rs m1,352230 588.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m583-73 -801.4%   
Profit after tax Rs m939302 310.8%  
Gross profit margin %12.58.3 149.8%  
Effective tax rate %43.1-31.7 -136.2%   
Net profit margin %8.52.5 341.5%  
BALANCE SHEET DATA
Current assets Rs m7,5236,884 109.3%   
Current liabilities Rs m2,2538,456 26.6%   
Net working cap to sales %47.7-13.0 -368.4%  
Current ratio x3.30.8 410.2%  
Inventory Days Days5262 84.6%  
Debtors Days Days41108 37.7%  
Net fixed assets Rs m1,2404,970 24.9%   
Share capital Rs m166113 146.5%   
"Free" reserves Rs m7,1672,875 249.3%   
Net worth Rs m7,3333,020 242.8%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m9,91213,347 74.3%  
Interest coverage xNM1.6-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.10.9 122.6%   
Return on assets %9.55.4 176.3%  
Return on equity %12.810.0 128.0%  
Return on capital %20.813.3 155.8%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m1,0155,843 17.4%   
Fx outflow Rs m3,0432,173 140.0%   
Net fx Rs m-2,0283,669 -55.3%   
CASH FLOW
From Operations Rs m537398 135.0%  
From Investments Rs m-476-1,635 29.1%  
From Financial Activity Rs m-2201,309 -16.8%  
Net Cashflow Rs m-16071 -224.0%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.6 505.6%  
FIIs % 1.0 17.6 5.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 39.6 73.5%  
Shareholders   28,591 20,750 137.8%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   NOVARTIS  ASTRAZENECA PHARMA  STRIDES PHARMA SCIENCE  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare MERCK With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Lower; Banking and Automobile Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Apr 23, 2019 03:35 PM

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS